Cash & equivalents decreased 27.3%
Cash & equivalents changed -27.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -27.3% from the comparable as-filed period.
Gross margin changed +319 basis points from the comparable as-filed period.
Gross profit changed +13.6% from the comparable as-filed period.
Inventory changed +16.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +117.6% from the comparable as-filed period.
Operating income changed +128.3% from the comparable as-filed period.
Operating margin changed +5059 basis points from the comparable as-filed period.
Research & development changed +8.9% from the comparable as-filed period.
Debt changed -5.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -7.0% from the comparable as-filed period.
Revenue changed +3.7% from the comparable as-filed period.
Stock-based compensation changed +2.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.